Axsome Therapeutics (AXSM) Tops Q1 EPS by 8c

Axsome Therapeutics (NASDAQ: AXSM) reported Q1 EPS of ($1.22), $0.08 better than the analyst estimate of ($1.30). Revenue for the quarter came in at $121.46 million versus the consensus estimate of $121.58 million.

For earnings history and earnings-related data on Axsome Therapeutics (AXSM) click here.

You May Also Be Interested In

• Walmart to pay $1.4 billion for Vibe.co acquisition - WSJ
• Active options: MSFT PLTR META GOOGL SOFI MSTR IREN AMC IBM SMCI HOOD AMD
• Constellation Brands (STZ) PT Lowered to $157 at Jefferies